Get started
GGG

GENETETHER THERAPEUTICS INC.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

GTTX chart


Full chart

Key stats


Market capitalization
‪856.27 K‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.020 CAD
Net income (FY)
‪−929.07 K‬ CAD
Revenue (FY)
0.00 CAD
Shares float
‪7.70 M‬
Beta (1Y)
1.95

About GENETETHER THERAPEUTICS INC.


Sector
Health Technology
Industry
Biotechnology
CEO
Roland Boivin
Website
genetether.com
Headquarters
Kelowna
Founded
2018
FIGI
BBG014XHHT68
GeneTether Therapeutics, Inc. is a genetic medicines company, which engages in the creation of gene editing therapies based on the GeneTether platform. The company was founded by Daren Graham, William J. Garner, and R. Geoffrey Sargent on February 12, 2018 and is headquartered in Kelowna, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

GTTX news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GTTX is 0.025 CAD — it hasn't changed in the past 24 hours. Watch GENETETHER THERAPEUTICS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange GENETETHER THERAPEUTICS INC. stocks are traded under the ticker GTTX.
GTTX stock hasn't changed in a week, the month change is a −16.67% fall, over the last year there was no change in GENETETHER THERAPEUTICS INC. price.
GTTX reached its all-time high on Mar 30, 2022 with the price of 0.680 CAD, and its all-time low was 0.005 CAD and was reached on Apr 24, 2023. View more price dynamics on GTTX chart.
See other stocks reaching their highest and lowest prices.
GTTX stock is 0.00% volatile and has beta coefficient of 1.95. Track GENETETHER THERAPEUTICS INC. stock price on the chart and check out the list of the most volatile stocks — is GENETETHER THERAPEUTICS INC. there?
Yes, you can track GENETETHER THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.
GTTX net income for the last quarter is ‪−147.48 K‬ CAD, while the quarter before that showed ‪−194.50 K‬ CAD of net income which accounts for 24.17% change. Track more GENETETHER THERAPEUTICS INC. financial stats to get the full picture.
No, GTTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GTTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETETHER THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETETHER THERAPEUTICS INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETETHER THERAPEUTICS INC. stock shows the sell signal. See more of GENETETHER THERAPEUTICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.